Cancer sufferer at Northampton General Hospital is first UK patient treated with drug to stop Covid A Northampton man with a form of blood cancer is the first patient in the UK to receive treatment trialling a drug to help vulnerable patients fight Covid-19.
The Rapid-Protection study will eventually be rolled out to around 350 participants aged over 18 at hospitals around the country. Northampton Chronicle and Echo
No comments:
Post a Comment